ASX Biotech Investing has always been the market’s most difficult arena. Yes tech and resources are risky spaces too, but at least a gold explorer can gain just off the…
There's a Biotech Patent Cliff coming over the next decade! Investors aren't giving this much attention, but we think they should because it could cause substantial upheaval in the biotech…
It has been a few years since investors have paid attention to biotech Opthea (ASX:OPT) on the scale that they have in the past week or so. Since its stellar…
There aren't many ASX stocks fighting diabetes, but the few that are have a big market opportunity ahead of them. And they are not just about fighting the condition directly but…
Here Are Our 5 Top ASX Health Stocks for 2025!
Avita Medical (ASX:AVH)
OK, first thing's first. We know this ASX health stock fell 14% on January 8 after…
Here are our 6 Best ASX Stocks for 2025!
Opthea (ASX:OPT)
Its been a long wait, but 2025 will finally be the year Opthea (ASX:OPT) investors receive Phase 3 results.…
The ASX Schools Sharemarket Game is on again! And it is a great way for school students to be introduced to the strategic functioning of the share markets. But just…
As FY24 has come to an end, we thought we'd list our best ASX Health Stocks for FY25! Traditionally, healthcare stocks are seen as defensive plays in dour markets. This…
FDA approval for ASX health stocks is the dream that just about all emerging companies in the sector are aspiring to. Just over 12 months ago, we predicted that Neuren…
As the new calendar year begins, we thought we would share our top 4 predictions for the ASX in 2024.
We hope all investors have a Happy New Year, although we…